PA
SWIM icon

PharVision Advisers’s Latham Group SWIM Stock Holding History

PharVision Advisers’s Portfolio SWIM Stock Details SWIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,576
Closed -$162K – 577
2025
Q4 		$162K Buy
25,576
+14,766
+137% +$103K 0.08% 604
2025
Q3 		$82.3K Buy
+10,810
New +$79.6K 0.05% 635

Other funds holding SWIM

PCM
Pamplona Capital Management New York $473M AUM 3.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

PharVision Advisers's SWIM Position: Q1 2026 in Review

PharVision Advisers sold out of Latham Group (SWIM) in Q1 2026, closing a stake of 25,576 shares — an estimated $162K sold.

PharVision Advisers first reported a position in SWIM in Q3 2025 and held it in 2 quarters. The position peaked at $162K in Q4 2025. 142 funds tracked by Wall St. Rank hold SWIM as of Q1 2026.

  • PharVision Advisers reported no remaining Latham Group position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 25,576 Latham Group shares in Q1 2026, an estimated $162K.
  • PharVision Advisers first reported a position in Latham Group in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Latham Group position peaked at $162K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Latham Group as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.